The objectives of this study are to estimate the efficacy and safety of the daily
administration of mifepristone 5 mg versus 10 mg for three months for the treatment of
uterine fibroids.
The hypothesis of the study is that both mifepristone doses reduce the volume of the myoma in
about 40% after 3 months of treatment.